Services
>
Medical Device CRO United States

Medical Device CRO United States

Mobius supports US-only medical device studies as well as multi-region clinical programs across the United States, Australia, and New Zealand. We work with MedTech sponsors on clinical trial strategy, feasibility, site activation, monitoring, data quality, CRO oversight, and rescue support.

Schedule a call

US medical device trials need more than CRO process

A US medical device study needs the right evidence question, the right sites, a realistic recruitment model, trained investigators and coordinators, clean escalation pathways, and data review that can identify issues while there is still time to act.

US
US-only clinical trial support for sponsors with US-specific evidence, site, market, or stakeholder needs.
MedTech
Medical device CRO support for feasibility, first-in-human, pivotal, post-market, digital health, SaMD, and AI-adjacent evidence programs.
Global
Evidence planning connected across the United States, Australia, and New Zealand where a multi-region pathway makes sense.

When sponsors come to Mobius

Medical device sponsors usually need practical judgement from people who understand how device studies actually fail.
01
Planning a first US study. Pressure-test the clinical question, site profile, endpoint structure, visit schedule, and operational assumptions before the protocol is locked.
02
Preparing pivotal or post-market evidence. Strengthen control over site selection, investigator training, monitoring, documentation, safety workflows, and data quality.
03
Running a US-only study. Get focused US trial support when the evidence question, patient population, market strategy, or stakeholder milestone is US-specific.
04
Rescuing an underperforming trial. Review studies where sites are open but not enrolling, monitoring reports are delayed, or the sponsor lacks clear visibility.

US medical device trial planning

A strong US study starts before the first site is activated. The important questions are practical: are the endpoints measurable, will sites see enough eligible patients, is the visit schedule realistic, and does the trial support the sponsor's next decision?

Mobius helps sponsors pressure-test these decisions early, including investigator experience, participant burden, device accountability, monitoring approach, data review, and escalation pathways.

Explore clinical trial strategy

Clinical trial strategy ->

Feasibility, monitoring, and data quality

US feasibility needs more than a generic site survey. Sponsors need to understand which sites can find the target population, follow the protocol, train the right staff, communicate issues quickly, and protect data quality under real-world workload.

  • Investigator and site profile development.
  • Feasibility outreach and site conversations.
  • Recruitment assumption review.
  • Site activation planning and bottleneck identification.
  • Monitoring strategy and site management.
  • Protocol deviation, missing data, and action-item review.

Explore clinical trial execution

Clinical trial execution ->

FDA-aware clinical evidence planning

Mobius does not replace legal or regulatory counsel, and we do not promise regulatory outcomes. But medical device trials need to be designed and run with regulatory expectations in mind.

For US studies, that may mean thinking carefully about intended use, patient population, endpoint selection, follow-up duration, device training, safety reporting, monitoring, data integrity, and future FDA-facing discussion needs.

Explore regulatory-aware evidence planning

Regulatory support ->

Relevant medical device experience

Use our case studies to see how Mobius supports medical device teams across feasibility, pivotal, AI, interventional, and patient-centred evidence programs.

AI
AI-powered skin cancer detection
FIH
Mitral valve innovation from early feasibility to pivotal study
Pivotal
World-first aspiration thrombectomy trial
Patient
Non-invasive pain relief device for pregnancy
See case studies ->

Questions sponsors ask about US medical device CRO support

Short answers for MedTech teams planning, running, or rescuing US medical device clinical studies.

Do you support US-only medical device studies?

Yes. Mobius supports US-only medical device studies as well as multi-region studies across the United States, Australia, and New Zealand. The right model depends on the sponsor's evidence needs, regulatory pathway, timelines, budget, and site access.

Can Mobius take over from another CRO?

Mobius can support CRO takeover or rescue planning where a study is underperforming. The first step is usually a structured review of recruitment, site activation, monitoring, data quality, vendor handover risk, and sponsor oversight needs.

What types of medical device studies can Mobius support?

Mobius supports medical device studies across feasibility, first-in-human, pivotal, post-market, digital health, SaMD/AI-adjacent, and patient-centred evidence programs.

Can Mobius help with FDA-facing clinical evidence planning?

Mobius supports FDA-aware clinical evidence planning and works alongside sponsor regulatory advisers where needed. We help connect the study design and operational plan to the evidence the sponsor needs, without replacing specialist regulatory or legal advice.

Can Mobius help with US site selection and feasibility?

Yes. Mobius can support site profile development, feasibility outreach, recruitment assumption review, investigator and site evaluation, and site activation planning for US medical device studies.

Talk to Mobius ->

Talk to Mobius about a US medical device trial

Ask Mobius to review your US trial plan, current study status, CRO oversight model, or rescue options.

Schedule A Call